Business Context and Reporting Period
This Form 8-K Current Report is filed by Mind Medicine (MindMed) Inc. (not Definium Therapeutics, Inc.) for the reporting date of April 1, 2024. The registrant is incorporated in British Columbia and trades on The Nasdaq Stock Market LLC under the symbol "MNMD". The filing addresses a voluntary delisting event rather than periodic financial results.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance event regarding stock exchange listings.
Material Changes
- Voluntary Delisting: The Company elected to voluntarily delist its common shares from Cboe Canada.
- Effective Date: The delisting is effective at the close of markets on April 10, 2024.
- Continued Listing: Common shares will continue to trade on Nasdaq under the symbol "MNMD".
- Regulatory Acceptance: The notice of voluntary delisting has been accepted by Cboe Canada.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the timing of the delisting and the anticipated continued listing on Nasdaq. Management notes that actual results may differ materially due to risks and uncertainties, including the satisfaction of customary closing conditions for underwritten offerings and concurrent private placements. The Company disclaims any obligation to update these forward-looking statements except as required by law.
Investor Verification Checklist
- Verify the final delisting date of April 10, 2024, on Cboe Canada.
- Confirm continued trading status and liquidity on Nasdaq under symbol "MNMD".
- Review the attached Press Release (Exhibit 99.1) for additional context on the strategic rationale.
- Note that this filing does not contain updated financial performance data; refer to the most recent 10-K or 10-Q for financial metrics.